Cargando…

Delayed Onset Anthracycline-Associated Cardiotoxicity Presenting as Acute Decompensated Heart Failure Seven Years After Chemotherapy Completion

Anthracyclines are a class of chemotherapeutic agents commonly used to treat a variety of malignancies including leukemias and lymphomas. Cardiotoxicity is a well-known clinical adverse effect of anthracyclines with a diverse range of presentations and manifestations. While the vast majority of card...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tran, Dan B, AlAshi, Amro K, Hernandez, Annellys
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412847/ https://www.ncbi.nlm.nih.gov/pubmed/34513492 http://dx.doi.org/10.7759/cureus.16920

Ejemplares similares

Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)

Anthracycline Cardiotoxicity in a Patient with Diffuse Large B-Cell Lymphoma: A Case Report
por: Teixeira da Silva, Francisco, et al.
Publicado: (2020)

Pediatric Chemotherapy Drugs Associated With Cardiotoxicity
por: Hitawala, Gazala, et al.
Publicado: (2021)

Incidence of long-term cardiotoxicity and evolution of the systolic function in patients with breast cancer treated with anthracyclines
por: Caballero, Rebeca Mata, et al.
Publicado: (2022)

Management of New Onset Amphetamine-Induced Acute Decompensated Heart Failure in a Young Adult: Case Report
por: Breier, Yuli, et al.
Publicado: (2023)

Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy
por: Broeyer, F. J. F., et al.
Publicado: (2008)

Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents
por: Briasoulis, Alexandros, et al.
Publicado: (2022)

Frequency of Atrial Fibrillation in Patients Presenting With Decompensated Heart Failure
por: Ullah, Rafi, et al.
Publicado: (2021)

Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020)

Association of Cardiotoxicity With Doxorubicin and Trastuzumab: A Double-Edged Sword in Chemotherapy
por: Gabani, Mohanad, et al.
Publicado: (2021)

Decompensated Heart Failure as the Initial Presentation of Multiple Myeloma: A Case Report
por: Maisuradze, Nodari, et al.
Publicado: (2022)

Acute Decompensated Heart Failure Due to Combined Ischemic Cardiomyopathy and Cardiac Amyloidosis
por: Bosah, Arinze N, et al.
Publicado: (2022)

Case of Anthracycline-induced Cardiogenic Shock: A Call to Optimize Modifiable Cardiac Risk Factors Prior to Chemotherapy
por: Gabriel, Andre, et al.
Publicado: (2019)

Left Ventricular Thrombus After Acute Decompensated Heart Failure in the Setting of Ischemic Cardiomyopathy
por: Satish, Mohan, et al.
Publicado: (2019)

Ultra‐high dose intravenous nitroglycerin in an ESRD patient with acutely decompensated heart failure
por: Gyory, Michael, et al.
Publicado: (2021)

Atrial Fibrillation With Decompensated Heart Failure Complicated With Non-ST Elevation Myocardial Infarction
por: Shaban, Eman E, et al.
Publicado: (2022)

A Case of Acute Decompensated Heart Failure Complicated by Cardiorenal Syndrome Treated With Ultrafiltration
por: Mandal, Gaurav, et al.
Publicado: (2022)

A Case of Chronic Pulmonary Embolism Resulting in Pulmonary Hypertension and Decompensated Right Heart Failure
por: Hosna, Asma U, et al.
Publicado: (2022)

Dosing Challenges and Benefits of Vericiguat in a Patient With Decompensated Heart Failure: A Case Report
por: Speranza-Sánchez, Mario, et al.
Publicado: (2023)

Cardiotoxicity: Myocardium or Endothelium
por: Montañez-Valverde, Raúl A, et al.
Publicado: (2018)

Cardiotoxicity by Anthracycline Regimen Chemotherapy Prolonged T Peak to T End Interval
por: Iqbal, Mohammad, et al.
Publicado: (2020)

The correlation between heart rate variability index and vulnerability prognosis in patients with acute decompensated heart failure
por: Liu, Hongbo, et al.
Publicado: (2023)

Pharmacological and Non-pharmacological Strategies for Volume Overload in Acute Decompensated Congestive Heart Failure: A Review Article
por: Zafar, Meer R, et al.
Publicado: (2020)

Demographics and Characteristics of Acutely Decompensated Heart Failure (ADHF) Patients in a Tertiary Care Center in Saudi Arabia
por: Alalawi, Hassan, et al.
Publicado: (2023)

The role of iron in anthracycline cardiotoxicity
por: Gammella, Elena, et al.
Publicado: (2014)

Updates in Anthracycline-Mediated Cardiotoxicity
por: Nebigil, Canan G., et al.
Publicado: (2018)

Metabolic Aspects of Anthracycline Cardiotoxicity
por: Russo, Michele, et al.
Publicado: (2021)

Genetics of Anthracycline-Associated Cardiotoxicity
por: Al-Otaibi, Talal Khalid, et al.
Publicado: (2022)

Anthracycline-induced cardiotoxicity and senescence
por: Booth, Laura K., et al.
Publicado: (2022)

Outcomes of Urgent Transcatheter Aortic Valve Replacement in Patients With Acute Decompensated Heart Failure: A Single-Center Experience
por: Chen, Kai, et al.
Publicado: (2020)

Exercise Attenuates Cardiotoxicity of Anthracycline Chemotherapy Measured by Global Longitudinal Strain
por: Costello, Benedict T., et al.
Publicado: (2019)

Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study
por: Linares Ballesteros, Adriana, et al.
Publicado: (2021)

Reversible Systolic Heart Failure in a Patient on Ibrutinib Chemotherapy
por: Khaja, Misbahuddin, et al.
Publicado: (2022)

Acute Onset of Heart Failure and Renal Failure Due to Pacemaker Syndrome
por: Ashraf, Afreen, et al.
Publicado: (2023)

Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
por: Volkova, Maria, et al.
Publicado: (2011)

Cardiotoxicity of anthracycline therapy: current perspectives
por: Valcovici, Mihaela, et al.
Publicado: (2016)

Risk Factors for Anthracycline-Induced Cardiotoxicity
por: Qiu, Shuo, et al.
Publicado: (2021)

Coronary microcirculation damage in anthracycline cardiotoxicity
por: Galán-Arriola, Carlos, et al.
Publicado: (2021)

Novel Therapeutics for Anthracycline Induced Cardiotoxicity
por: Vuong, Jacqueline T., et al.
Publicado: (2022)

Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment
por: Cai, Fengfeng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hrbnosjgpblu0pfdnbume7rpla